MyFinsight
Home
Blog
About
Contact
Download
Download image
Manufacturing
$31,383,684
(128.44%↑ Y/Y)
Licensing
$205,567
(-67.17%↓ Y/Y)
Total revenue
$31,589,251
(119.92%↑ Y/Y)
Change in fair value of
derivative financial...
$11,817,375
(200.75%↑ Y/Y)
Interest income
$83,602
(1541.83%↑ Y/Y)
Gross profit
$12,953,175
(111.68%↑ Y/Y)
Cost of
manufacturing
$18,636,076
(126.03%↑ Y/Y)
Other income
(expense), net
$11,820,773
(200.60%↑ Y/Y)
Income from operations
$9,012,943
(720.99%↑ Y/Y)
Interest expense and
amortization of debt issuance...
$80,204
(3.35%↑ Y/Y)
Total operating
expenses
$3,940,232
(-21.53%↓ Y/Y)
Income (gain) before
income taxes
$20,833,716
(295.57%↑ Y/Y)
General and
administrative
$2,466,336
(-9.48%↓ Y/Y)
Research and development
$1,040,665
(-41.99%↓ Y/Y)
Depreciation and
amortization
$388,135
(-10.26%↓ Y/Y)
Non-cash compensation
through issuance of...
$45,096
(-36.10%↓ Y/Y)
Net income (gain)
$18,593,806
(270.71%↑ Y/Y)
Income tax expense
$2,239,910
(836.52%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
ELITE PHARMACEUTICALS INC NV (ELTP)
ELITE PHARMACEUTICALS INC NV (ELTP)